Liminal BioSciences gibt FDA-Zulassung für seinen Biologics License Application für Ryplazim® (Plasminogen, human-tvmh) bekannt ...Middle East

LAVAL, QC und CAMBRIDGE, England, 5. Juni 2021 /PRNewswire/ -- Liminal BioSciences Inc. (Nasdaq: LMNL) („Liminal BioSciences" oder das "Unternehmen") gab heute bekannt, dass die US-amerikanische Food & Drug Administration (FDA) Ryplazim® (Plasminogen, human-tvmh) („Ryplazim®") für die...

Hence then, the article about liminal biosciences gibt fda zulassung fur seinen biologics license application fur ryplazim plasminogen human tvmh bekannt was published today ( Saturday 05/06/2021 - 10:00 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Liminal BioSciences gibt FDA-Zulassung für seinen Biologics License Application für Ryplazim® (Plasminogen, human-tvmh) bekannt )

Also on site :

• Russia-Ukraine war: List of key events, day 1,426
• Rangers’ Cody Bradford Targeting Return In May From Elbow Surgery
• '90s Trash Metal Band Releases New Single Ahead of Farewell Album